Inactive Instrument

Other languages Gujarat Themis Biosyn Ltd Bombay S.E.

Equities

GTHM

INE942C01029

End-of-day quote Bombay S.E. Other stock markets
-	-

05-14	Gujarat Themis Biosyn Gets Board Nod for Issue of Bonus Shares	MT
05-14	Gujarat Themis Biosyn Names Technology Chief	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gujarat Themis Biosyn Gets Board Nod for Issue of Bonus Shares	05-14
Gujarat Themis Biosyn Names Technology Chief	05-14
Gujarat Themis Biosyn Limited Recommends Dividend for Financial Year Ended March 31, 2024, Payable on or After July 15, 2024	05-14
Gujarat Themis Biosyn Limited Approves Management Changes	05-14
Gujarat Themis Biosyn Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-14
Gujarat Themis Biosyn Limited Approves an Interim Dividend for the Year 2023-24	02-10
Gujarat Themis Biosyn Limited Approves Interim Dividend for the Financial Year 2023-24	02-10
Gujarat Themis Biosyn Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-10
Gujarat Themis Biosyn Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-04
Gujarat Themis Biosyn Limited Recommends Dividend for Financial Year Ended March 31, 2023	13/05/23
Gujarat Themis Biosyn Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023	13/05/23
Gujarat Themis Biosyn Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	03/02/23
Gujarat Themis Biosyn Names New CEO	05/01/23
Gujarat Themis Biosyn Limited Appoints Tapas Guha Thakurata as Chief Executive Officer	05/01/23
Gujarat Themis Biosyn Board Declares Interim Dividend for Fiscal 2023	21/11/22
Gujarat Themis Biosyn Limited Approves Declaration of an Interim Dividend for the Financial Year 2022-23	21/11/22
Gulf Oil Lubricants' Net Profit Slides in Fiscal Q2	09/11/22
Gujarat Themis Biosyn's Net Profit Climbs in Fiscal Q2	09/11/22
Gujarat Themis Biosyn Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	07/11/22
Themis Medicare Limited entered into share purchase agreement to acquire additional 6.47% stake in Gujarat Themis Biosyn Limited from Pharmaceutical Business Group Limited for approximately INR 700 million.	06/11/22

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Gujarat Themis Biosyn Ltd Bombay S.E.

Equities

GTHM

INE942C01029

Other languages

Filters